Rituxan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ ®) for Hypophosphatasia
Condition:   Hypophosphatasia Interventions:   Drug: methotrexate;   Drug: rituximab;   Drug: bortezomib;   Drug: IVIg;   Drug: Folic Acid Sponsor:   Alexion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials